Top Executives at Vaccine Manufacturers Sold $500 Million in Stocks Last Year

HeadlineFeb 18, 2021

New research shows top executives at Pfizer, Moderna, Merck and other vaccine manufacturers sold nearly $500 million of stock last year as the value in the companies soared due to the pandemic.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation